Dose Finding Study of Single Dose GHB11L1 in Healthy Adults

Summary

The purpose of this phase IIa trial is to evaluate the immunogenicity of a single dose of GHB11L1 administered by liquid nasal spray for vaccination against influenza A (H1N1) virus. This study is also performed to assess safety, tolerability and pharmacokinetics (shedding) of a single dose of GHB11L1 administered by liquid nasal spray.

Timeline

Start

2009-12

Primary completion

2010-05

Completion

2010-05

Drugs

Indications